News
OHE Models Future UK Medicines Spending for the ABPI
3 July 2012
The Office of Health Economics has developed and run a model for the ABPI to project UK NHS expenditure on medicines. On 2 July, the ABPI…
Register Now for the OHE Conference on Drug Development in 2022
2 July 2012
Throughout its 50-year history, OHE has been a leader in contributing to the understanding of important trends in health care and in the life science industries,…
Register Now: OHE Lunchtime Seminar on Innovation
26 June 2012
In response to the R&D productivity crisis affecting the pharmaceutical industry, “big pharma” is seeking to source therapeutics from small and medium sized enterprises (SMEs). In…
Save the Date: Drug Development in 2022, OHE’s 50th Anniversary Conference
21 June 2012
The Economics of Drug Development in 2022 On 8 October, 2012, in celebration of its 50th anniversary, OHE will be holding an important conference to consider…
Register Now: SMEs as a Source of Innovation – OHE Lunchtime Seminar, 4 July
20 June 2012
In response to the R&D productivity crisis affecting the pharmaceutical industry, “big pharma” is seeking to source therapeutics from small and medium sized enterprises (SMEs). In…
New OHE Consulting Report Explores the Many Faces of Innovation
19 June 2012
Now available from the OHE website, this report provides a clear explanation of the complex nature of innovation in medicines. A fully revised and expanded version…
Prospective Observational Studies: Whether, When and How to Use
18 June 2012
OHE’s Adrian Towse is co-author on the recent report by the ISPOR Good Research Practices Task Force on assessing comparative effectiveness using prospective observational studies.
New Seminar Briefing: Is Pharmaceutical R&D Experiencing a Productivity Crisis?
14 June 2012
Just published are the results of an OHE Lunchtime Seminar given by Prof Riccaboni, from the University of Trento. In this publication, he explores whether R&D…
HTAinSite: Recent Changes in the Database of NICE Decisions
7 June 2012
HTAinSiteImagine being able to find, in ONE minute or less, which NICE Technology Assessments (TAs) make specific reference to QALY thresholds of £20,000 or £30,000, for…